BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Gembillo G, Sessa C, Santoro D. Advances in the pathophysiology and treatment of focal segmental glomerulosclerosis: The importance of a timely and tailored approach. World J Nephrol 2025; 14(2): 103039 [PMID: 40568339 DOI: 10.5527/wjn.v14.i2.103039]
URL: https://www.wjgnet.com/2220-6124/full/v14/i2/103039.htm
Number Citing Articles
1
Mehmoona Zahid, Fatima Akram, Mahnoor Nasir, Rukhshan Zahid. Molecular Mechanisms and Physiological Effects of Genetic Polymorphisms in Chronic Kidney DiseaseCurrent Science, Engineering and Technology 2026; 5(3) doi: 10.2174/0130506115434332251209071723
2
Shams Ismayilova, Onur Mutlu, Jamila Bayramova, Afig Berdeli. Podocyte dysfunction in kidney diseases: Mechanisms and therapeutic advancesScience Progress 2026; 109(3) doi: 10.1177/00368504261475956
3
Guido Gembillo, Chiara Casuscelli, Alberto La Spada, Ylenia Di Pietro, Giulia Cipressa, Domenico Santoro, Claudia Lo Re. Angiotensin system modulation in focal segmental glomerulosclerosis: pharmacological basis and clinical implicationsExpert Opinion on Pharmacotherapy 2026;  doi: 10.1080/14656566.2026.2706076
4
Che-Hsi Wu, Jia-Jung Lee, Daw-Yang Hwang, Chen-Yu Wei, Sheng-Yang Li, Jih-Jin Tsai. Cascade of opportunistic infections in focal segmental glomerulosclerosis under dual immunosuppressive therapy: a case reportFrontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1838232
5
Bartosz Rutka, Alicja Danieluk, Natalia Wiewiórska-Krata, Krzysztof Mucha. Multi-Modal, Machine Learning-Driven Framework Integrating Multi-Omics for Personalized Chronic Kidney Disease ManagementJournal of Clinical Medicine 2026; 15(13) doi: 10.3390/jcm15135213